Market Closed -
Bombay S.E.
06:00:55 2024-07-08 am EDT
|
5-day change
|
1st Jan Change
|
421.2
INR
|
-0.53%
|
|
+1.96%
|
-16.34%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,934
|
8,848
|
12,696
|
35,107
|
24,983
|
11,323
|
Enterprise Value (EV)
1 |
2,825
|
9,533
|
13,902
|
36,844
|
28,117
|
13,603
|
P/E ratio
|
28.9
x
|
17.4
x
|
10.5
x
|
31.6
x
|
22.7
x
|
13.2
x
|
Yield
|
0.81%
|
0.8%
|
1.05%
|
0.39%
|
0.38%
|
0.24%
|
Capitalization / Revenue
|
2.43
x
|
1.28
x
|
1.88
x
|
4.65
x
|
2.17
x
|
1.08
x
|
EV / Revenue
|
2.34
x
|
1.38
x
|
2.06
x
|
4.88
x
|
2.44
x
|
1.29
x
|
EV / EBITDA
|
10.6
x
|
5.2
x
|
7.74
x
|
18
x
|
13.7
x
|
8.28
x
|
EV / FCF
|
32.4
x
|
142
x
|
-24.6
x
|
-47.4
x
|
-15.7
x
|
29.8
x
|
FCF Yield
|
3.08%
|
0.7%
|
-4.07%
|
-2.11%
|
-6.37%
|
3.36%
|
Price to Book
|
7.99
x
|
3.41
x
|
3.44
x
|
7
x
|
4.08
x
|
1.64
x
|
Nbr of stocks (in thousands)
|
7,281
|
11,729
|
24,298
|
27,153
|
27,153
|
27,153
|
Reference price
2 |
403.0
|
754.4
|
522.5
|
1,293
|
920.0
|
417.0
|
Announcement Date
|
8/8/18
|
9/6/19
|
9/5/20
|
9/5/21
|
9/5/22
|
8/23/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,206
|
6,923
|
6,749
|
7,548
|
11,533
|
10,518
|
EBITDA
1 |
265.4
|
1,834
|
1,796
|
2,052
|
2,053
|
1,643
|
EBIT
1 |
243.5
|
1,698
|
1,641
|
1,872
|
1,762
|
1,356
|
Operating Margin
|
20.18%
|
24.53%
|
24.32%
|
24.8%
|
15.27%
|
12.89%
|
Earnings before Tax (EBT)
1 |
252.3
|
1,712
|
1,828
|
1,849
|
1,762
|
1,372
|
Net income
1 |
163.4
|
1,213
|
1,385
|
1,146
|
1,133
|
881.2
|
Net margin
|
13.54%
|
17.52%
|
20.52%
|
15.18%
|
9.82%
|
8.38%
|
EPS
2 |
13.93
|
43.36
|
49.53
|
40.97
|
40.51
|
31.50
|
Free Cash Flow
1 |
87.06
|
67.16
|
-565.7
|
-776.5
|
-1,790
|
456.6
|
FCF margin
|
7.22%
|
0.97%
|
-8.38%
|
-10.29%
|
-15.52%
|
4.34%
|
FCF Conversion (EBITDA)
|
32.81%
|
3.66%
|
-
|
-
|
-
|
27.79%
|
FCF Conversion (Net income)
|
53.29%
|
5.54%
|
-
|
-
|
-
|
51.81%
|
Dividend per Share
2 |
3.250
|
6.000
|
5.500
|
5.000
|
3.500
|
1.000
|
Announcement Date
|
8/8/18
|
9/6/19
|
9/5/20
|
9/5/21
|
9/5/22
|
8/23/23
|
Fiscal Period: March |
2022 Q3
|
2022 Q4
|
---|
Net sales
1 |
-
|
3,476
|
EBITDA
1 |
-
|
569.9
|
EBIT
|
-
|
-
|
Operating Margin
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
|
299.4
|
-
|
Net margin
|
-
|
-
|
EPS
|
-
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
2/7/22
|
5/25/22
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
685
|
1,206
|
1,738
|
3,135
|
2,280
|
Net Cash position
1 |
109
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.3736
x
|
0.6716
x
|
0.8468
x
|
1.527
x
|
1.387
x
|
Free Cash Flow
1 |
87.1
|
67.2
|
-566
|
-776
|
-1,790
|
457
|
ROE (net income / shareholders' equity)
|
30.7%
|
73.4%
|
42.9%
|
28.8%
|
22.1%
|
14.8%
|
ROA (Net income/ Total Assets)
|
18.5%
|
39%
|
18.6%
|
15.1%
|
10.7%
|
6.97%
|
Assets
1 |
884
|
3,110
|
7,429
|
7,564
|
10,604
|
12,643
|
Book Value Per Share
2 |
50.50
|
221.0
|
152.0
|
185.0
|
226.0
|
254.0
|
Cash Flow per Share
2 |
9.850
|
3.100
|
5.220
|
4.730
|
9.220
|
2.850
|
Capex
1 |
64
|
-
|
2,051
|
1,713
|
1,209
|
1,517
|
Capex / Sales
|
5.31%
|
-
|
30.39%
|
22.7%
|
10.49%
|
14.42%
|
Announcement Date
|
8/8/18
|
9/6/19
|
9/5/20
|
9/5/21
|
9/5/22
|
8/23/23
|
|
1st Jan change
|
Capi.
|
---|
| -16.34% | 140M | | +2.28% | 102B | | -10.54% | 59.6B | | +77.62% | 48.89B | | +3.15% | 35.03B | | -0.66% | 30.47B | | +1.91% | 18.26B | | +17.26% | 17.47B | | +4.18% | 13.62B | | +81.61% | 13.18B |
Other Commodity Chemicals
|